How to facilitate early diagnosis of CNS involvement in malignant lymphoma

Agnieszka Korfel, Martha Nowosielski, Javier Pardo-Moreno, Francisco Javier Penalver, Gabriele Buda, Hind Bennani, Myrto Costopoulos, Magali Le Garff-Tavernier, Carole Soussain, Mathias Schmid, Jose Alberto Orfao, Michael Glantz

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: Making the diagnosis of secondary CNS involvement in lymphoma can be difficult due to unspecific signs and symptoms, limited accessibility of brain/myelon parenchyma and low sensitivity and/or specifity of imaging and cerebrospinal fluid (CSF) examination currently available. Areas covered: MRI of the total neuroaxis followed by CSF cytomorphology and flow cytometry are methods of choice when CNS lymphoma (CNSL) is suspected. To reduce the numerous pitfalls of these examinations several aspects should be considered. New CSF biomarkers might be of potential diagnostic value. Attempts to standardize response criteria are presented. Expert commentary: Diagnosing CNSL remains challenging. Until diagnostic methods combining high sensitivity with high specifity are routinely introduced, high level of awareness and optimal utilization of examinations currently available are needed to early diagnose this potentially devastating disease.

Original languageEnglish (US)
Pages (from-to)1081-1091
Number of pages11
JournalExpert Review of Hematology
Volume9
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Cerebrospinal Fluid
Early Diagnosis
Lymphoma
Signs and Symptoms
Spinal Cord
Flow Cytometry
Biomarkers
Brain

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Korfel, A., Nowosielski, M., Pardo-Moreno, J., Penalver, F. J., Buda, G., Bennani, H., ... Glantz, M. (2016). How to facilitate early diagnosis of CNS involvement in malignant lymphoma. Expert Review of Hematology, 9(11), 1081-1091. https://doi.org/10.1080/17474086.2016.1242405
Korfel, Agnieszka ; Nowosielski, Martha ; Pardo-Moreno, Javier ; Penalver, Francisco Javier ; Buda, Gabriele ; Bennani, Hind ; Costopoulos, Myrto ; Le Garff-Tavernier, Magali ; Soussain, Carole ; Schmid, Mathias ; Orfao, Jose Alberto ; Glantz, Michael. / How to facilitate early diagnosis of CNS involvement in malignant lymphoma. In: Expert Review of Hematology. 2016 ; Vol. 9, No. 11. pp. 1081-1091.
@article{beca5c8cdd0b47228e9d439416b0dee9,
title = "How to facilitate early diagnosis of CNS involvement in malignant lymphoma",
abstract = "Introduction: Making the diagnosis of secondary CNS involvement in lymphoma can be difficult due to unspecific signs and symptoms, limited accessibility of brain/myelon parenchyma and low sensitivity and/or specifity of imaging and cerebrospinal fluid (CSF) examination currently available. Areas covered: MRI of the total neuroaxis followed by CSF cytomorphology and flow cytometry are methods of choice when CNS lymphoma (CNSL) is suspected. To reduce the numerous pitfalls of these examinations several aspects should be considered. New CSF biomarkers might be of potential diagnostic value. Attempts to standardize response criteria are presented. Expert commentary: Diagnosing CNSL remains challenging. Until diagnostic methods combining high sensitivity with high specifity are routinely introduced, high level of awareness and optimal utilization of examinations currently available are needed to early diagnose this potentially devastating disease.",
author = "Agnieszka Korfel and Martha Nowosielski and Javier Pardo-Moreno and Penalver, {Francisco Javier} and Gabriele Buda and Hind Bennani and Myrto Costopoulos and {Le Garff-Tavernier}, Magali and Carole Soussain and Mathias Schmid and Orfao, {Jose Alberto} and Michael Glantz",
year = "2016",
month = "11",
day = "1",
doi = "10.1080/17474086.2016.1242405",
language = "English (US)",
volume = "9",
pages = "1081--1091",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Expert Reviews Ltd.",
number = "11",

}

Korfel, A, Nowosielski, M, Pardo-Moreno, J, Penalver, FJ, Buda, G, Bennani, H, Costopoulos, M, Le Garff-Tavernier, M, Soussain, C, Schmid, M, Orfao, JA & Glantz, M 2016, 'How to facilitate early diagnosis of CNS involvement in malignant lymphoma', Expert Review of Hematology, vol. 9, no. 11, pp. 1081-1091. https://doi.org/10.1080/17474086.2016.1242405

How to facilitate early diagnosis of CNS involvement in malignant lymphoma. / Korfel, Agnieszka; Nowosielski, Martha; Pardo-Moreno, Javier; Penalver, Francisco Javier; Buda, Gabriele; Bennani, Hind; Costopoulos, Myrto; Le Garff-Tavernier, Magali; Soussain, Carole; Schmid, Mathias; Orfao, Jose Alberto; Glantz, Michael.

In: Expert Review of Hematology, Vol. 9, No. 11, 01.11.2016, p. 1081-1091.

Research output: Contribution to journalReview article

TY - JOUR

T1 - How to facilitate early diagnosis of CNS involvement in malignant lymphoma

AU - Korfel, Agnieszka

AU - Nowosielski, Martha

AU - Pardo-Moreno, Javier

AU - Penalver, Francisco Javier

AU - Buda, Gabriele

AU - Bennani, Hind

AU - Costopoulos, Myrto

AU - Le Garff-Tavernier, Magali

AU - Soussain, Carole

AU - Schmid, Mathias

AU - Orfao, Jose Alberto

AU - Glantz, Michael

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Introduction: Making the diagnosis of secondary CNS involvement in lymphoma can be difficult due to unspecific signs and symptoms, limited accessibility of brain/myelon parenchyma and low sensitivity and/or specifity of imaging and cerebrospinal fluid (CSF) examination currently available. Areas covered: MRI of the total neuroaxis followed by CSF cytomorphology and flow cytometry are methods of choice when CNS lymphoma (CNSL) is suspected. To reduce the numerous pitfalls of these examinations several aspects should be considered. New CSF biomarkers might be of potential diagnostic value. Attempts to standardize response criteria are presented. Expert commentary: Diagnosing CNSL remains challenging. Until diagnostic methods combining high sensitivity with high specifity are routinely introduced, high level of awareness and optimal utilization of examinations currently available are needed to early diagnose this potentially devastating disease.

AB - Introduction: Making the diagnosis of secondary CNS involvement in lymphoma can be difficult due to unspecific signs and symptoms, limited accessibility of brain/myelon parenchyma and low sensitivity and/or specifity of imaging and cerebrospinal fluid (CSF) examination currently available. Areas covered: MRI of the total neuroaxis followed by CSF cytomorphology and flow cytometry are methods of choice when CNS lymphoma (CNSL) is suspected. To reduce the numerous pitfalls of these examinations several aspects should be considered. New CSF biomarkers might be of potential diagnostic value. Attempts to standardize response criteria are presented. Expert commentary: Diagnosing CNSL remains challenging. Until diagnostic methods combining high sensitivity with high specifity are routinely introduced, high level of awareness and optimal utilization of examinations currently available are needed to early diagnose this potentially devastating disease.

UR - http://www.scopus.com/inward/record.url?scp=84993992729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993992729&partnerID=8YFLogxK

U2 - 10.1080/17474086.2016.1242405

DO - 10.1080/17474086.2016.1242405

M3 - Review article

C2 - 27677656

AN - SCOPUS:84993992729

VL - 9

SP - 1081

EP - 1091

JO - Expert Review of Hematology

JF - Expert Review of Hematology

SN - 1747-4086

IS - 11

ER -

Korfel A, Nowosielski M, Pardo-Moreno J, Penalver FJ, Buda G, Bennani H et al. How to facilitate early diagnosis of CNS involvement in malignant lymphoma. Expert Review of Hematology. 2016 Nov 1;9(11):1081-1091. https://doi.org/10.1080/17474086.2016.1242405